Compare CVS Health Corp (CVS) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs The Coca-Cola Co K — how do they compare? CVS Health Corp trades at $93.49 (market cap $122.36B), while The Coca-Cola Co K trades at $86.52 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 3.1× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| CVS | KO | |
|---|---|---|
Market Cap | $122.36B | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $89.08 |
52-Week Low | $64.88 | $65.67 |
Enterprise Value | $184.71B | $400.93B |
Dividend Yield | 2.78% | 2.44% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Coca-Cola (KO) trades at $86.51, down 0.62% on the day, with a bullish technical outlook supported by moving averages and key indicators like RSI at 69.16. The company shows strong fundamentals with a 27.33% net margin in 2025 and consistent earnings beats, alongside a robust dividend history of 64 consecutive annual increases. Recent news highlights institutional buying and stable demand trends, per Bank of America on April 10, 2026.
The stock presents a favorable investment case with a consensus price target of $95.83, implying ~11% upside, backed by analyst buy ratings at 60.4%. Risks include rising debt levels and regional demand volatility, but KO's global brand and profitability support long-term value for dividend-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
